Global Long-acting Injectable Medications Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Market Analysis by Type
- 1.3.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2020 VS 2026
- 1.3.2 First-generation
- 1.3.3 Second-generation
- 1.4 Market by Application
- 1.4.1 Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2026
- 1.4.2 Schizophrenia
- 1.4.3 Contraception
- 1.4.4 HIV
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Long-acting Injectable Medications Market Perspective (2015-2026)
- 2.2 Long-acting Injectable Medications Growth Trends by Regions
- 2.2.1 Long-acting Injectable Medications Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2015-2020)
- 2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2021-2026)
- 2.3 Long-acting Injectable Medications Industry Dynamic
- 2.3.1 Long-acting Injectable Medications Market Trends
- 2.3.2 Long-acting Injectable Medications Market Drivers
- 2.3.3 Long-acting Injectable Medications Market Challenges
- 2.3.4 Long-acting Injectable Medications Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Long-acting Injectable Medications Players by Market Size
- 3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2015-2020)
- 3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2015-2020)
- 3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
- 3.4 Global Long-acting Injectable Medications Market Concentration Ratio
- 3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2019
- 3.5 Key Players Long-acting Injectable Medications Area Served
- 3.6 Key Players Long-acting Injectable Medications Product Solution and Service
- 3.7 Date of Enter into Long-acting Injectable Medications Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Long-acting Injectable Medications Breakdown Data by Type
- 4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
- 4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)
5 Long-acting Injectable Medications Breakdown Data by Application
- 5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
- 5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Long-acting Injectable Medications Market Size (2015-2026)
- 6.2 North America Long-acting Injectable Medications Market Size by Type (2015-2020)
- 6.3 North America Long-acting Injectable Medications Market Size by Application (2015-2020)
- 6.4 North America Long-acting Injectable Medications Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Long-acting Injectable Medications Market Size (2015-2026)
- 7.2 Europe Long-acting Injectable Medications Market Size by Type (2015-2020)
- 7.3 Europe Long-acting Injectable Medications Market Size by Application (2015-2020)
- 7.4 Europe Long-acting Injectable Medications Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2015-2026)
- 8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2015-2020)
- 8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2015-2020)
- 8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
9 Latin America
- 9.1 Latin America Long-acting Injectable Medications Market Size (2015-2026)
- 9.2 Latin America Long-acting Injectable Medications Market Size by Type (2015-2020)
- 9.3 Latin America Long-acting Injectable Medications Market Size by Application (2015-2020)
- 9.4 Latin America Long-acting Injectable Medications Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2015-2026)
- 10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2015-2020)
- 10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2015-2020)
- 10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
11Key Players Profiles
- 11.1 Eli Lilly
- 11.1.1 Eli Lilly Company Details
- 11.1.2 Eli Lilly Business Overview
- 11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
- 11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2015-2020))
- 11.1.5 Eli Lilly Recent Development
- 11.2 Alkermes
- 11.2.1 Alkermes Company Details
- 11.2.2 Alkermes Business Overview
- 11.2.3 Alkermes Long-acting Injectable Medications Introduction
- 11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.2.5 Alkermes Recent Development
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Company Details
- 11.3.2 Johnson & Johnson Business Overview
- 11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
- 11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.3.5 Johnson & Johnson Recent Development
- 11.4 Zogenix
- 11.4.1 Zogenix Company Details
- 11.4.2 Zogenix Business Overview
- 11.4.3 Zogenix Long-acting Injectable Medications Introduction
- 11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.4.5 Zogenix Recent Development
- 11.5 DURECT
- 11.5.1 DURECT Company Details
- 11.5.2 DURECT Business Overview
- 11.5.3 DURECT Long-acting Injectable Medications Introduction
- 11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.5.5 DURECT Recent Development
- 11.6 Mapi Pharma
- 11.6.1 Mapi Pharma Company Details
- 11.6.2 Mapi Pharma Business Overview
- 11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
- 11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.6.5 Mapi Pharma Recent Development
- 11.7 GSK
- 11.7.1 GSK Company Details
- 11.7.2 GSK Business Overview
- 11.7.3 GSK Long-acting Injectable Medications Introduction
- 11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.7.5 GSK Recent Development
- 11.8 MedinCell
- 11.8.1 MedinCell Company Details
- 11.8.2 MedinCell Business Overview
- 11.8.3 MedinCell Long-acting Injectable Medications Introduction
- 11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.8.5 MedinCell Recent Development
- 11.9 Oakwood Labs
- 11.9.1 Oakwood Labs Company Details
- 11.9.2 Oakwood Labs Business Overview
- 11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
- 11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.9.5 Oakwood Labs Recent Development
- 11.10 Nanomi
- 11.10.1 Nanomi Company Details
- 11.10.2 Nanomi Business Overview
- 11.10.3 Nanomi Long-acting Injectable Medications Introduction
- 11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2015-2020)
- 11.10.5 Nanomi Recent Development
- 11.11 Pharmathen
- 10.11.1 Pharmathen Company Details
- 10.11.2 Pharmathen Business Overview
- 10.11.3 Pharmathen Long-acting Injectable Medications Introduction
- 10.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2015-2020)
- 10.11.5 Pharmathen Recent Development
- 11.12 Kashiv BioSciences
- 10.12.1 Kashiv BioSciences Company Details
- 10.12.2 Kashiv BioSciences Business Overview
- 10.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
- 10.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2015-2020)
- 10.12.5 Kashiv BioSciences Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Long-acting Injectable Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-acting Injectable Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
First-generation
Second-generation
Market segment by Application, split into
Schizophrenia
Contraception
HIV
Others
Based on regional and country-level analysis, the Long-acting Injectable Medications market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
In the competitive analysis section of the report, leading as well as prominent players of the global Long-acting Injectable Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen